Literature DB >> 23628837

A dose-response study of dexmedetomidine administered as the primary sedative in infants following open heart surgery.

Felice Su1, Susan C Nicolson, Athena F Zuppa.   

Abstract

OBJECTIVE: To evaluate the dose-response relationship of dexmedetomidine in infants with congenital heart disease postoperative from open heart surgery.
DESIGN: Prospective open-label dose-escalation pharmacokinetic-pharmacodynamic study.
SETTING: Tertiary pediatric cardiac ICU. PATIENTS: Thirty-six evaluable infants, 1-24 months old, postoperative from open heart surgery requiring mechanical ventilation.
INTERVENTIONS: Cohorts of 12 infants were enrolled sequentially to one of the three IV loading doses of dexmedetomidine (0.35, 0.7, and 1 mcg/kg) over 10 minutes followed by respective continuous infusions (0.25, 0.5, and 0.75 mcg/kg/hr) for up to 24 hours.
MEASUREMENTS AND MAIN RESULTS: Dexmedetomidine plasma concentrations were obtained at timed intervals during and following discontinuation of infusion. Pharmacodynamic variables evaluated included sedation scores, supplemental sedation and analgesia medication administration, time to tracheal extubation, respiratory function, and hemodynamic parameters. Infants achieved a deeper sedation measured by the University of Michigan Sedation Scale score (2.6 vs 1) despite requiring minimal supplemental sedation (0 unit doses/hr) and fewer analgesic medications (0.07 vs 0.15 unit doses/hr) while receiving dexmedetomidine compared with the 12-hour follow-up period. Thirty-one patients were successfully extubated while receiving the dexmedetomidine infusion. Only one patient remained intubated due to oversedation during the infusion. While receiving dexmedetomidine, there was a decrease in heart rate compared with baseline, 132 versus 161 bpm, but there was an increase in heart rate compared with postinfusion values, 132 versus 128 bpm. There was no statistically or clinically significant change in mean arterial blood pressure.
CONCLUSIONS: Dexmedetomidine administration in infants following open heart surgery can provide improved sedation with reduction in supplemental medication requirements, leading to successful extubation while receiving a continuous infusion. The postoperative hemodynamic changes that occur in infants postoperative from open heart surgery are multifactorial. Although dexmedetomidine may play a role in decreasing heart rate immediately postoperative, the changes were not clinically significant and did not fall below postinfusion heart rates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23628837      PMCID: PMC3720685          DOI: 10.1097/PCC.0b013e31828a8800

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  19 in total

1.  Dexmedetomidine for pediatric sedation for computed tomography imaging studies.

Authors:  Keira P Mason; Steven E Zgleszewski; Jennifer L Dearden; Raymond S Dumont; Michele A Pirich; Cynthia D Stark; Peggy D'Angelo; Shann Macpherson; Paulette J Fontaine; Linda Connor; David Zurakowski
Journal:  Anesth Analg       Date:  2006-07       Impact factor: 5.108

2.  Fast-track postoperative care for neonatal cardiac surgery: a single-institute experience.

Authors:  Yuka Yamasaki; Nobuaki Shime; Takako Miyazaki; Masaaki Yamagishi; Satoru Hashimoto; Yoshifumi Tanaka
Journal:  J Anesth       Date:  2011-04-13       Impact factor: 2.078

3.  Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease.

Authors:  Constantinos Chrysostomou; Rukmini Komarlu; Steven Lichtenstein; Dana Shiderly; Gaurav Arora; Richard Orr; Peter D Wearden; Victor O Morell; Ricardo Munoz; Edmund H Jooste
Journal:  Intensive Care Med       Date:  2010-03-06       Impact factor: 17.440

4.  Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results.

Authors:  A Koroglu; S Demirbilek; H Teksan; O Sagir; A K But; M O Ersoy
Journal:  Br J Anaesth       Date:  2005-03-11       Impact factor: 9.166

5.  Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia.

Authors:  Constantinos Chrysostomou; Victor O Morell; Peter Wearden; Joan Sanchez-de-Toledo; Edmund H Jooste; Lee Beerman
Journal:  Congenit Heart Dis       Date:  2012-05-22       Impact factor: 2.007

6.  Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations.

Authors:  Constantinos Chrysostomou; Joan Sanchez-de-Toledo; Peter Wearden; Edmund H Jooste; Steven E Lichtenstein; Patrick M Callahan; Tunga Suresh; Elizabeth O'Malley; Dana Shiderly; Jamie Haney; Masahiro Yoshida; Richard Orr; Ricardo Munoz; Victor O Morell
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

7.  Use of dexmedetomidine in children after cardiac and thoracic surgery.

Authors:  Constantinos Chrysostomou; Sylvie Di Filippo; Ana-Maria Manrique; Carol G Schmitt; Richard A Orr; Alfonso Casta; Erin Suchoza; Janine Janosky; Peter J Davis; Ricardo Munoz
Journal:  Pediatr Crit Care Med       Date:  2006-03       Impact factor: 3.624

8.  Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children.

Authors:  John W Berkenbosch; Patricia C Wankum; Joseph D Tobias
Journal:  Pediatr Crit Care Med       Date:  2005-07       Impact factor: 3.624

9.  Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS).

Authors:  S Malviya; T Voepel-Lewis; A R Tait; S Merkel; K Tremper; N Naughton
Journal:  Br J Anaesth       Date:  2002-02       Impact factor: 9.166

10.  Population pharmacokinetics of dexmedetomidine in infants after open heart surgery.

Authors:  Felice Su; Susan C Nicolson; Marc R Gastonguay; Jeffrey S Barrett; Peter C Adamson; David S Kang; Rodolfo I Godinez; Athena F Zuppa
Journal:  Anesth Analg       Date:  2010-05-01       Impact factor: 5.108

View more
  7 in total

Review 1.  Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

2.  Pediatric Perioperative Clinical Pharmacy Practice: Clinical Considerations and Management: An Opinion of the Pediatrics and Perioperative Care Practice and Research Networks of the American College of Clinical Pharmacy.

Authors:  Elizabeth J Beckman; Sara Hovey; Deborah S Bondi; Gourang Patel; Richard H Parrish
Journal:  J Pediatr Pharmacol Ther       Date:  2022-08-19

3.  Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure.

Authors:  Mary Jo C Grant; James B Schneider; Lisa A Asaro; Brenda L Dodson; Brent A Hall; Shari L Simone; Allison S Cowl; Michele M Munkwitz; David Wypij; Martha A Q Curley
Journal:  Pediatr Crit Care Med       Date:  2016-12       Impact factor: 3.624

4.  Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.

Authors:  Kanecia O Zimmerman; Huali Wu; Matthew Laughon; Rachel G Greenberg; Richard Walczak; Scott R Schulman; P Brian Smith; Christoph P Hornik; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Anesth Analg       Date:  2019-12       Impact factor: 6.627

Review 5.  Practical approaches to sedation and analgesia in the newborn.

Authors:  Christopher McPherson; Cynthia M Ortinau; Zachary Vesoulis
Journal:  J Perinatol       Date:  2020-11-29       Impact factor: 2.521

6.  Results of a phase 1 multicentre investigation of dexmedetomidine bolus and infusion in corrective infant cardiac surgery.

Authors:  Athena F Zuppa; Susan C Nicolson; Nicole S Wilder; Juan C Ibla; Erin A Gottlieb; Kristin M Burns; Mario Stylianou; Felicia Trachtenberg; Hua Ni; Tera H Skeen; Dean B Andropoulos
Journal:  Br J Anaesth       Date:  2019-10-14       Impact factor: 11.719

Review 7.  Efficacy and safety of dexmedetomidine in maintaining hemodynamic stability in pediatric cardiac surgery: a systematic review and meta-analysis.

Authors:  Qing Wang; Chuikai Chen; Li Wang
Journal:  J Pediatr (Rio J)       Date:  2021-07-09       Impact factor: 2.990

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.